Mental Health

Patient reviews options for their mental health treatment

Pharmacogenetic Testing in Mental Health

Minimizing Trial and Error during Medication Therapy

In a large study sponsored by the National Institute of Mental Health (NIMH), less than 30% of depressed patients responded adequately to their initial antidepressant.1 Even after four medication trials spanning nine months total, almost 25% of patients still experienced unresolved depression.2,3

Benefits of Millennium PGTSM in Mental Health

  • Identifies potentially harmful drug interactions resulting from polypharmacy
  • Assists clinicians in determining the most effective medication and dose, potentially reducing multiple medication trials
  • Provides evidence-based and guideline driven information with in-house clinical expertise for additional support
Patient reviews Pharmacogenetic Test result to help guide their Mental Health treatment
Doctor enjoying the benefit of utilizing Millennium Health's Drug Testing solutions

Request Information on Millennium PGT

Use the form below to request additional information about utilizing Millennium PGT in treating your patients.

  1. Trivedi M, Rush J et al. Evaluation of Outcomes with Citalopram for Depression using Measurement-based Care in STAR*D: Implications for Clinical Practice. Am J Psychiatry 2006; 163:28-40.
  2. Rush J, Trivedi M et al. Bupropion- SR, Sertraline, or Venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354:1231-42.
  3. Rush J, Trivedi M et al. Acute and Longer-term Outcomes in Depressed Outpatients requiring One or Several Treatment Steps: A STAR*D Report. Am J Psychiatry 2006; 163:1905-1917.